Xencor, Inc. reports results for the quarter ended June 30 - Earnings Summary

Xencor

05/08/2026 22:29

Xencor, Inc. XNCR.OQ reported a quarterly adjusted loss of 29 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -41 cents.  The mean expectation of thirteen analysts for the quarter was for a loss of 83 cents per share. Wall Street expected results to range from $-1.08 to -65 cents per share.
Revenue rose 17.5% to $51.22 million from a year ago; analysts expected $18.92 million. 
Xencor, Inc.'s reported EPS for the quarter was a loss of 29 cents​.
The company reported a quarterly loss of $21.73 million.
Xencor, Inc. shares had risen by 23.7% this quarter and gained 30.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for Xencor, Inc. is $28.00, about 28.9% above its last closing price of $19.92
This summary was machine generated from LSEG data August 5 at 09:29 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.83
-0.29
Beat
Mar. 31 2026 
-0.77
-1.71
Missed
Dec. 31 2025 
-0.60
-0.09
Beat
Sep. 30 2025 
-0.69
-0.08
Beat